McKesson (MCK:NYS) Fundamental Valuation Report

Fundamental Valuation Report

McKesson(MCK:NYS)

Healthcare:Medical Distribution

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$122.04 (USD) 10/01/2019

Weighted Valuation
$117.84 (USD)

Overall Rating
Fairly valued to slightly Overvalued by 3.4%

Valuation Models Analyst Consensus: $129.00 (USD)
(in order of importance) Comparables: $94.32 (USD)
Multiples: $131.39 (USD)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Overvalued on a Comparable Valuation
Asset: Undervalued on an Asset Valuation

Company Overview (MCK:NYS USD)

Price 122.04
Range 117.45 – 122.59
52 week 108.23 – 176.72
Open 118.08
Vol / Avg. 2.16M/2.05M
Mkt cap 23.84B
P/E 187.92
Div/yield 1.30/0.01
EPS 0.32
Shares 195.38M
Beta 1.06

Company Description

McKesson is a major distributor of pharmaceuticals and medical products in the United States. The firm plays a critical role along the pharmaceutical supply chain as it is able to procure and distribute drugs more efficiently than its pharmacy clients and pharma manufacturing suppliers.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for MCK:NYS

Using a discounted cash flow model we generated an intrinsic value of $333.33 (USD) for MCK:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

MCK:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $333.33 1% 5% 1% 5%
WACC (or Ke) 7.57 $428.29 $270.19
Terminal Growth Rate 2.60 $276.25 $419.16
Tax Rate 0.22 $354.11 $312.54
Cash Flow 4,663,990,800 $316.10 $350.55
Capital Expenditures -389,400,000 $331.98 $334.68
Long Term Debt 8,107,000,000 $335.40 $331.25

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $94.32 (USD) for MCK:NYS. We also generated a valuation of $124.18 (USD) using other metrics and comparables.
The comparable companies were AmerisourceBergen (ABC:NYS), Cardinal Health (CAH:NYS) and Henry Schein (HSIC:NAS).

Company MCK:NYS End Date Value
Earnings/Share $0.65 (USD)
Book Value/Share $47.73 (USD)
Sales/Share $1,033.96 (USD)
Cash Flow/Share $16.29 (USD)
EBITDA/Share $7.22 (USD)
Price Based on Comps Adjustment Factor (%)
$12.51 (USD) -19.4
$185.36 (USD) 12.6
$386.22 (USD) -69.8
$168.00 (USD) -48.3
$72.05 (USD) -12.6
MCK:NYS Ratios Used Average Values ABC:NYS CAH:NYS HSIC:NAS
175.35 PE Ratio 19.25 9.88 18.66 29.19
2.31 PB Ratio 3.88 5.38 2.25 4.03
0.11 PS Ratio 0.37 0.10 0.10 0.92
6.78 PCF Ratio 12.68 11.61 7.13 19.30
19.94 EV to EBITDA 9.98 9.37 7.09 13.47

Multiples

Using a multiples approach we generated a valuation of  $131.39 (USD) for MCK:NYS

Company MCK:NYS End Date Value
Earnings/Share $0.65 (USD)
Book Value/Share $47.73 (USD)
Sales/Share $1,033.96 (USD)
Cash Flow/Share $16.29 (USD)
EBITDA/Share $7.22 (USD)
Price Based on Comps Adjustment Factor
$12.07 (USD) 0
$193.87 (USD) 0
$195.98 (USD) 0
$176.32 (USD) 0
$78.73 (USD) 0
Ratios Ratio Average
PE Ratio 18.57
PB Ratio 4.06
PS Ratio 0.19
PCF Ratio 10.82
EV to EBITDA 10.90

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  MCK:NYS for the last 10 years was  3.85

We ran the Adjusted Book Value for  MCK:NYS and generated a book value of  $46.17 (USD)
By multiplying these we get an adjusted valuation of  $177.97 (USD)

Analyst Data

In the Stockcalc database there are 2 analysts that provide a valuation for MCK:NYS. The 2 analysts have a concensus valuation for MCK:NYS for 2020 of $129.00 (USD).

MCK:NYS McKesson

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
1 2 1 3.0000 Hold 2019-1-9

Current Price: 122.04 USD

Analyst Consensus
USD Millions 2019 2020 2021
Mean EPS 13.53 14.12 14.75
# EPS Analysts 4 3 1
Mean Revenue 214,825.40 221,526.40 228,560.60
# Revenue Analysts 2 2 1
Mean Target Price 129.00
Mean Cash Flow 15.44 13.78 23.82
Mean EBITDA 4,076.70 4,285.30 4,545.80
Mean Net Income 2,700.40 2,785.60 2,815.00
Mean Debt Outstanding 5,223.30 5,223.30 5,223.30
Mean Tax Rate
Mean Growth Rate 7.64
Mean Capital Expenditure 578.50 590.00

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


AmerisourceBergen (ABC:NYS) Fundamental Valuation Report

Fundamental Valuation Report

AmerisourceBergen(ABC:NYS)

Healthcare:Medical Distribution

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$87.43 (USD) 21/11/2018

Weighted Valuation
$96.00 (USD)

Overall Rating
Undervalued by 9.8%

Valuation Models Analyst Consensus: $96.00 (USD)
(in order of importance)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Undervalued on a Comparable Valuation
Asset: Undervalued on an Asset Valuation

Company Overview (ABC:NYS USD)

Price 87.43
Range 87.10 – 89.30
52 week 78.98 – 105.48
Open 88.52
Vol / Avg. 1.12M/1.61M
Mkt cap 18.53B
P/E 11.61
Div/yield 1.52/0.02
EPS 7.53
Shares 211.93M
Beta 0.97

Company Description

AmerisourceBergen is one of three major pharmaceutical distributors in the U.S., with highly efficient distribution assets. The firm’s activities include procurement, inventory management, reimbursement consulting, sales forecasts, and logistics services. The firm is also a wholesale leader within the high-growth specialty distribution niche.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for ABC:NYS

Using a discounted cash flow model we generated an intrinsic value of $365.85 (USD) for ABC:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

ABC:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $365.85 1% 5% 1% 5%
WACC (or Ke) 8.17 $458.58 $303.18
Terminal Growth Rate 3.00 $309.56 $449.15
Tax Rate -0.37 $377.18 $354.52
Cash Flow 2,715,400,067 $350.31 $381.39
Capital Expenditures 0 $365.85 $365.85
Long Term Debt 4,407,216,000 $366.89 $364.81

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $143.90 (USD) for ABC:NYS. We also generated a valuation of $86.29 (USD) using other metrics and comparables.
The comparable companies were Cardinal Health (CAH:NYS), Henry Schein (HSIC:NAS) and McKesson (MCK:NYS).

Company ABC:NYS End Date Value
Earnings/Share $7.53 (USD)
Book Value/Share $14.62 (USD)
Sales/Share $740.00 (USD)
Cash Flow/Share $9.61 (USD)
EBITDA/Share $8.52 (USD)
Price Based on Comps Adjustment Factor (%)
$348.03 (USD) 20.2
$46.02 (USD) 0.0
$303.15 (USD) -79.2
$93.99 (USD) -44.9
$122.50 (USD) 25.8
ABC:NYS Ratios Used Average Values CAH:NYS HSIC:NAS MCK:NYS
18.03 PE Ratio 96.82 62.47 29.97 198.03
6.02 PB Ratio 3.15 2.49 4.34 2.61
0.12 PS Ratio 0.41 0.12 0.99 0.12
9.16 PCF Ratio 11.82 5.76 22.04 7.66
13.20 EV to EBITDA 14.38 7.67 13.58 21.89

Multiples

Using a multiples approach we generated a valuation of  $135.37 (USD) for ABC:NYS

Company ABC:NYS End Date Value
Earnings/Share $7.53 (USD)
Book Value/Share $14.62 (USD)
Sales/Share $740.00 (USD)
Cash Flow/Share $9.61 (USD)
EBITDA/Share $8.52 (USD)
Price Based on Comps Adjustment Factor
$216.11 (USD) 0
$138.81 (USD) 0
$100.04 (USD) 0
$74.28 (USD) 0
$147.59 (USD) 0
Ratios Ratio Average
PE Ratio 28.70
PB Ratio 9.50
PS Ratio 0.14
PCF Ratio 7.73
EV to EBITDA 17.32

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  ABC:NYS for the last 10 years was  9.41

We ran the Adjusted Book Value for  ABC:NYS and generated a book value of  $13.76 (USD)
By multiplying these we get an adjusted valuation of  $129.50 (USD)

Analyst Data

In the Stockcalc database there are 3 analysts that provide a valuation for ABC:NYS. The 3 analysts have a concensus valuation for ABC:NYS for 2019 of $96.00 (USD).

ABC:NYS AmerisourceBergen

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
3 1 0 4.4000 Outperform 2018-11-20

Current Price: 87.43 USD

Analyst Consensus
USD Millions 2019 2020
Mean EPS 7.01 7.49
# EPS Analysts 3 2
Mean Revenue 178,314.30 188,754.80
# Revenue Analysts 2 1
Mean Target Price 96.00
Mean Cash Flow 11.61 11.78
Mean EBITDA 2,448.10 2,513.70
Mean Net Income 1,508.80 1,606.50
Mean Debt Outstanding
Mean Tax Rate
Mean Growth Rate 8.68
Mean Capital Expenditure 462.70 459.00

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


Cardinal Health (CAH:NYS) Fundamental Valuation Report

Fundamental Valuation Report

Cardinal Health(CAH:NYS)

Healthcare:Medical Distribution

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$53.65 (USD) 07/11/2018

Weighted Valuation
$59.67 (USD)

Overall Rating
Undervalued by 11.2%

Valuation Models Analyst Consensus: $59.67 (USD)
(in order of importance)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Undervalued on a Comparable Valuation
Asset: Undervalued on an Asset Valuation

Company Overview (CAH:NYS USD)

Price 53.65
Range 52.59 – 53.70
52 week 48.40 – 75.23
Open 52.80
Vol / Avg. 2.9M/3.78M
Mkt cap 16.09B
P/E 66.23
Div/yield 1.86/0.04
EPS 0.81
Shares 299.86M
Beta 0.95

Company Description

Cardinal Health is a major distributor of pharmaceuticals and medical supplies to pharmacies and hospitals. It is also a major logistical partner for many branded manufacturers, providing market forecasting, product production, inventory efficiency, and distribution services to these players. Its largest retail pharmacy customer is CVS Health retail pharmacy operations.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for CAH:NYS

Using a discounted cash flow model we generated an intrinsic value of $191.45 (USD) for CAH:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

CAH:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $191.45 1% 5% 1% 5%
WACC (or Ke) 6.16 $244.61 $156.13
Terminal Growth Rate 1.20 $159.41 $239.68
Tax Rate 0.02 $201.44 $181.53
Cash Flow 3,203,722,175 $181.33 $201.58
Capital Expenditures -170,800,000 $190.98 $191.92
Long Term Debt 5,532,000,000 $192.38 $190.53

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $70.42 (USD) for CAH:NYS. We also generated a valuation of $97.20 (USD) using other metrics and comparables.
The comparable companies were AmerisourceBergen (ABC:NYS), Henry Schein (HSIC:NAS) and McKesson (MCK:NYS).

Company CAH:NYS End Date Value
Earnings/Share $0.81 (USD)
Book Value/Share $20.21 (USD)
Sales/Share $434.31 (USD)
Cash Flow/Share $8.79 (USD)
EBITDA/Share $9.24 (USD)
Price Based on Comps Adjustment Factor (%)
$66.43 (USD) -10.2
$88.25 (USD) -0.5
$178.27 (USD) -72.3
$85.19 (USD) -50.4
$150.61 (USD) -19.0
CAH:NYS Ratios Used Average Values ABC:NYS HSIC:NAS MCK:NYS
62.47 PE Ratio 82.01 18.03 29.97 198.03
2.50 PB Ratio 4.37 6.15 4.34 2.61
0.12 PS Ratio 0.41 0.12 0.99 0.12
5.76 PCF Ratio 12.95 9.16 22.04 7.66
7.71 EV to EBITDA 16.30 13.45 13.58 21.89

Multiples

Using a multiples approach we generated a valuation of  $73.33 (USD) for CAH:NYS

Company CAH:NYS End Date Value
Earnings/Share $0.81 (USD)
Book Value/Share $20.21 (USD)
Sales/Share $434.31 (USD)
Cash Flow/Share $8.79 (USD)
EBITDA/Share $9.24 (USD)
Price Based on Comps Adjustment Factor
$16.32 (USD) 0
$76.75 (USD) 0
$92.52 (USD) 0
$89.10 (USD) 0
$91.97 (USD) 0
Ratios Ratio Average
PE Ratio 20.15
PB Ratio 3.80
PS Ratio 0.21
PCF Ratio 10.14
EV to EBITDA 9.96

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  CAH:NYS for the last 10 years was  3.73

We ran the Adjusted Book Value for  CAH:NYS and generated a book value of  $19.61 (USD)
By multiplying these we get an adjusted valuation of  $73.14 (USD)

Analyst Data

In the Stockcalc database there are 3 analysts that provide a valuation for CAH:NYS. The 3 analysts have a concensus valuation for CAH:NYS for 2019 of $59.67 (USD).

CAH:NYS Cardinal Health

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
3 2 0 4.2000 Outperform 2018-11-6

Current Price: 53.65 USD

Analyst Consensus
USD Millions 2019 2020
Mean EPS 4.89 5.38
# EPS Analysts 4 3
Mean Revenue 140,572.30 145,159.80
# Revenue Analysts 2 2
Mean Target Price 59.67
Mean Cash Flow 6.21 8.17
Mean EBITDA 2,951.40 3,018.50
Mean Net Income 1,467.10 1,625.80
Mean Debt Outstanding 4,026.00 4,026.00
Mean Tax Rate
Mean Growth Rate 59.29
Mean Capital Expenditure 538.10 577.90

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


ING Groep (ING:NYS) and McKesson (MCK:NYS) Downgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Downgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been downgraded by at least one analyst in the last few days.

Why Do Companies Get Downgraded?

Companies can get downgraded for a number of reasons but primarily due to reduced future earnings potential due to loss of contracts, faultering product lines, increasing costs relative to revenue or financial risk.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
ING ING Groep NV 1 1 1 0 1 0 3.2500 3.6000 Hold
MCK McKesson Corp 2 0 2 0 1 0 3.4000 3.6667 Hold
WIT Wipro Ltd 1 0 1 0 0 0 4.0000 4.5000 Outperform
ABC AmerisourceBergen Corp 3 1 1 0 0 0 4.4000 4.5000 Outperform
LEN.B Lennar Corp 3 1 1 0 0 0 4.4000 4.5000 Outperform
LEN Lennar Corp 3 1 1 0 0 0 4.4000 4.5000 Outperform
IVZ Invesco Ltd 4 1 2 0 0 0 4.2857 4.3333 Outperform
DPLO Diplomat Pharmacy Inc 0 0 1 0 0 0 3.0000 4.0000 Hold
RAD Rite Aid Corp 0 0 1 0 1 0 2.0000 2.3333 Underperform
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
NSU Nevsun Resources Ltd 0 0 4 0 3 0 2.1429 2.5714 Underperform
RSI Rogers Sugar Inc 0 1 4 0 0 0 3.2000 3.6000 Hold
BNE Bonterra Energy Corp 4 3 5 0 1 0 3.6923 3.7857 Outperform
TDG Trinidad Drilling Ltd 2 2 6 0 1 0 3.3636 3.4545 Hold
LGD Liberty Gold Corp 2 1 1 0 0 0 4.2500 4.3333 Outperform
American Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
NSU Nevsun Resources Ltd 0 0 4 0 3 0 2.1429 2.5714 Underperform
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
PCAR PACCAR Inc 1 0 6 0 0 0 3.2857 3.5714 Hold
HSIC Henry Schein Inc 3 0 3 1 0 0 3.7143 3.8750 Outperform
XRAY Dentsply Sirona Inc 1 0 5 0 0 0 3.3333 3.5714 Hold
MDSO Medidata Solutions Inc 1 0 1 0 0 0 4.0000 4.3333 Outperform
HAFC Hanmi Financial Corp 1 0 1 0 0 0 4.0000 5.0000 Outperform

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

ING:NYS ING Groep

http://www.ing.com
ING Groep has 56435 employees and is headquartered in Netherlands.
ING Groep NV operates in the financial services domain. Its key areas of operation include retail and commercial banking.

MCK:NYS McKesson

http://www.mckesson.com
McKesson has 78000 employees and is headquartered in United States.
McKesson Corp provides medicines, pharmaceutical supplies, information and care management products and services across the healthcare industry. It operates with two segments namely McKesson Distribution Solutions and McKesson Technology Solutions.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

Alphabet (GOOGL:NAS) and Anadarko Petroleum (APC:NYS) Upgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.

Why Do Companies Get Upgraded?

Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
APC Anadarko Petroleum Corp 7 0 1 0 0 0 4.7500 4.7143 Buy
ABC AmerisourceBergen Corp 2 1 3 0 0 0 3.8333 3.7143 Outperform
O Realty Income Corp 1 0 3 0 1 0 3.0000 2.8000 Hold
ACC American Campus Communities Inc 1 0 3 0 0 0 3.5000 3.0000 Hold
BMS Bemis Co Inc 1 0 2 0 1 0 3.0000 2.3333 Hold
SLCA US Silica Holdings Inc 2 0 1 0 0 0 4.3333 4.0000 Outperform
BIG Big Lots Inc 2 0 1 0 0 0 4.3333 3.6667 Outperform
DSW DSW Inc 1 0 2 0 0 0 3.6667 3.0000 Outperform
APRN Blue Apron Holdings Inc 2 0 0 0 1 0 3.6667 3.0000 Outperform
USPH US Physical Therapy Inc 1 0 1 0 0 0 4.0000 3.0000 Outperform
HCLP Hi-Crush Partners LP 1 1 0 0 0 0 4.5000 4.0000 Outperform
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
DGC Detour Gold Corp 5 3 4 0 0 0 4.0833 4.0769 Outperform
WTE Westshore Terminals Investment Corp 1 1 3 0 0 0 3.6000 3.4000 Outperform
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
GOOGL Alphabet Inc 9 0 3 0 1 0 4.2308 4.1667 Outperform
GOOG Alphabet Inc 9 0 3 0 1 0 4.2308 4.1667 Outperform
GOOD Gladstone Commercial Corp 1 0 1 0 0 0 4.0000 3.0000 Outperform
ASPS Altisource Portfolio Solutions SA 0 0 1 0 0 0 3.0000 1.0000 Hold
AXAS Abraxas Petroleum Corp 1 0 1 0 0 0 4.0000 3.0000 Outperform
ALRN Aileron Therapeutics Inc 1 0 0 0 0 0 5.0000 0.0000 Buy

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

GOOGL:NAS Alphabet

https://www.abc.xyz
Alphabet has 75606 employees and is headquartered in United States.
Alphabet Inc is a provider of internet content products and portals. Its suite of brands includes Search, Android, YouTube, Apps, Maps & Ads.

APC:NYS Anadarko Petroleum

http://www.anadarko.com
Anadarko Petroleum has 4500 employees and is headquartered in United States.
Anadarko Petroleum Corp is engaged in the exploration and production of oil and natural gas. Its asset base includes conventional and unconventional properties in the U.S. and deep-water oil and gas projects in the Gulf of Mexico and Africa.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

Verizon Communications (VZ:NYS) and Autodesk (ADSK:NAS) Upgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.

Why Do Companies Get Upgraded?

Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
VZ Verizon Communications Inc 1 0 6 0 0 0 3.2857 3.2500 Hold
ABC AmerisourceBergen Corp 2 1 4 0 0 0 3.7143 3.5714 Outperform
O Realty Income Corp 1 0 3 0 1 0 3.0000 2.5000 Hold
COH Coach Inc 7 0 2 0 0 0 4.5556 4.4000 Buy
URI United Rentals Inc 2 0 7 0 0 0 3.4444 3.2222 Hold
MSCI MSCI Inc 2 0 2 0 1 0 3.4000 3.2000 Hold
DO Diamond Offshore Drilling Inc 1 0 3 0 2 0 2.6667 2.6000 Hold
FCPT Four Corners Property Trust Inc 0 0 1 0 0 0 3.0000 0.0000 Hold
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
SAP Saputo Inc 1 2 3 0 0 0 3.6667 3.5000 Outperform
CHR Chorus Aviation Inc 3 4 1 0 0 0 4.2500 4.1250 Outperform
KDX Klondex Mines Ltd 1 3 5 0 0 0 3.5556 3.5000 Outperform
WIR.U WPT Industrial Real Estate Investment Trust 2 1 1 0 0 0 4.2500 4.0000 Outperform
American Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
KLDX Klondex Mines Ltd 1 3 5 0 0 0 3.5556 3.5000 Outperform
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
ADSK Autodesk Inc 6 0 1 1 0 0 4.3750 4.2857 Outperform
GRMN Garmin Ltd 1 0 2 0 0 0 3.6667 3.0000 Outperform
SBNY Signature Bank 1 1 0 0 0 0 4.5000 4.0000 Outperform
HAIN The Hain Celestial Group Inc 0 1 4 0 1 0 2.8333 2.8000 Hold
LGIH LGI Homes Inc 1 0 1 0 0 0 4.0000 3.0000 Outperform
GOOD Gladstone Commercial Corp 0 0 1 0 0 0 3.0000 0.0000 Hold

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

VZ:NYS Verizon Communications

http://www.verizon.com
Verizon Communications has 161000 employees and is headquartered in United States.
Verizon Communications Inc is a provider of communications, information and entertainment products and services to consumers, businesses and governmental agencies. It offers voice, data and video services and solutions to wireless and wireline networks.

ADSK:NAS Autodesk

http://www.autodesk.com
Autodesk has 9000 employees and is headquartered in United States.
Autodesk Inc is engaged in the software industry. It develops software for a number of markets such as construction and media.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.